Stereotaxis Stock Slides Despite MAGiC Sweep Catheter FDA Submission

Stereotaxis (STXS) recently submitted an application seeking FDA regulatory clearance for its MAGiC Sweep catheter, which is the first-ever robotically navigated high-density electrophysiology (EP) mapping catheter. This submission marks a significant advancement in integrating Robotic Magnetic Navigation (RMN) technology with high-density mapping, aiming to enhance the precision and safety of cardiac arrhythmia treatments.With this regulatory submission, Stereotaxis is taking a critical step toward strengt ...